X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    $118bn Sales By 2026 Is What Japanese Pharma Can Expect

    $118bn Sales By 2026 Is What Japanese Pharma Can Expect

    Duchenne Muscular Dystrophy-Cancer Genetic Link Discovered

    Animal Testing Could See An End With An Artificial Model

    Bioavailability Enhancement Market Projects CAGR of 11%

    Hong Kong Gives $500mn Funding For Chinese Drug Development

    Germany Rolls First CAR-T Push For Muscle Inflammation Cure

    More Monitoring Required of Institutional Review Boards

    Stroke Patients To Get A Relief With Spinal Cord Stimulation

    Major Trial Reveals Simplified HIV Treatment Options Perfect

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    $118bn Sales By 2026 Is What Japanese Pharma Can Expect

    $118bn Sales By 2026 Is What Japanese Pharma Can Expect

    Duchenne Muscular Dystrophy-Cancer Genetic Link Discovered

    Animal Testing Could See An End With An Artificial Model

    Bioavailability Enhancement Market Projects CAGR of 11%

    Hong Kong Gives $500mn Funding For Chinese Drug Development

    Germany Rolls First CAR-T Push For Muscle Inflammation Cure

    More Monitoring Required of Institutional Review Boards

    Stroke Patients To Get A Relief With Spinal Cord Stimulation

    Major Trial Reveals Simplified HIV Treatment Options Perfect

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

Cancer Treatment Rates In NHS Hit An All-Time High In 2022

Content Team by Content Team
5th January 2023
in Facilities & Operation, News

The NHS has released encouraging statistics regarding cancer rates in the UK to kick off the new year. Over the past year, more patients than ever before the pandemic received essential NHS cancer treatments. Furthermore, the number of people who received life-saving NHS cancer checks increased, with over 2.8 million people seen, up by almost one-fifth from the same period prior to the pandemic (2.35 million in 2018–19). Over 10,000 checks are performed daily, with about 6% of them leading to a cancer diagnosis.

NHS staff have been functioning extraordinarily hard over the past year to recover from the pandemic, said Dame Cally Palmer, National Cancer Director for NHS England. It is because of their campaigning efforts and early diagnosis drives, as well as the fortitude of people like Dame Deborah James inspiring people to come forward, that they have seen and treated record numbers of people.

Investing in cancer awareness programmes that save lives

More people were welcomed and urged to come forward for checks as a result of the NHS’s first-ever doubling of investment in cancer awareness initiatives. Due to this, the NHS saw and treated a greater variety of patients. According to the data, 100,000 people last year had cancer diagnoses at stages one or two, when treatment is simpler (2021–2022).

According to Health and Social Care Secretary Steve Barclay, a record number of people underwent critical cancer treatment in the past year, up by more than 8,000 from the same period prior to the epidemic.

The NHS is investing in initiatives to promote awareness of symptoms and encourage people to come forward with concerns, as well as giving more cancer screenings than ever before and detecting record numbers of cancers at an early stage.

Providing community cancer patients with NHS care

Early cancer detection is essential for enhancing health outcomes and giving patients access to the best NHS cancer care. Since all GP teams have immediate access to life-saving testing for patients, waiting times are shorter, and thousands of patients can receive diagnoses or the all-clear faster. In addition, high street pharmacies will get funding to identify cancer symptoms, and pharmacist training will begin in January 2022.

The NHS has also quadrupled the number of community lung truck locations, resulting in the monthly MOT of over 30,000 people’s lungs, which can save their lives. As a result, almost 1,300 persons received early lung cancer diagnoses, with more than 77% receiving a stage one or stage two diagnosis.

The Institute of Cancer Research’s Chief Executive Officer, Professor Kristian Helin, stated that when cancer is detected early, therapy is frequently more effective, and the chances of a full recovery are significantly higher. This is why the likelihood of survival might significantly increase with an earlier cancer diagnosis. It is good to note that a record number of individuals underwent cancer therapy in the previous year and that a significant fraction of them were identified at an early stage when the illness is more amenable to treatment.

It is critical to motivate people to seek care if they exhibit symptoms. The Man Van, a mobile health clinic that offers free health screenings for men to promote timely detection of prostate cancer as well as other urological malignancies, was recently introduced by the ICR in collaboration with our hospital partner, The Royal Marsden.

This is one method they can innovate to make sure more malignancies are caught early.

Previous Post

Persistent Bacteria Are Undermining Antibiotic Treatment

Next Post

Hong Kong University Creates Bone Anabolic Aptamer Drug

Related Posts

$118bn Sales By 2026 Is What Japanese Pharma Can Expect
Drug Development

$118bn Sales By 2026 Is What Japanese Pharma Can Expect

2nd March 2023
Drug Development

Duchenne Muscular Dystrophy-Cancer Genetic Link Discovered

28th February 2023
News

Animal Testing Could See An End With An Artificial Model

28th February 2023
News

Bioavailability Enhancement Market Projects CAGR of 11%

28th February 2023
News

Booming Performance By The Life Sciences Biz In Wales

28th February 2023
Drug Development

Hong Kong Gives $500mn Funding For Chinese Drug Development

27th February 2023
Next Post
Dupixent Charts A Win Before The FDA Prurigo Nodularis Order

Hong Kong University Creates Bone Anabolic Aptamer Drug

Latest News

Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging
Europe

Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging

3rd March 2023
$118bn Sales By 2026 Is What Japanese Pharma Can Expect
Drug Development

$118bn Sales By 2026 Is What Japanese Pharma Can Expect

2nd March 2023
Drug Development

Duchenne Muscular Dystrophy-Cancer Genetic Link Discovered

28th February 2023
News

Animal Testing Could See An End With An Artificial Model

28th February 2023
News

Bioavailability Enhancement Market Projects CAGR of 11%

28th February 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In